Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: ASU Device: Patient breathes into device by
themselves after instruction by research assistant with regular respirations over a minimum 3-5
minutes providing approximately 60-100 respir
Sponsors
Canary Health Technologies
Eligibility
Inclusion criteria
Inclusion criteria: Participant is willing and able to give informed consent for participation in the study. Male or Female, Adult over the age of 18 No smoking, eating or alcohol for 4 hours prior to test Either COVID-19 Positive or COVID-19 Negative No perfume/cologne or heavy scent Subject who is able to comply with the study requirements, as defined in the present protocol, at the Investigatorâ??s discretion Able (in the Investigators opinion) and willing to comply with all study requirements. Diagnosed with required disease/severity/symptoms, or, if healthy volunteer study: beingood health
Exclusion criteria
Exclusion criteria: Age Any serious injury or illness likely to preclude completion of the trial. Frequent alcohol or recreational drug use. Hospitalized. Undergoing active chemotherapy. Fever in uninfected controls. Hypoxia, defined as pulse oximetry lower than 92% (90% in smokers and those with chronic lung disease). Respiratory disease such as COPD and Asthma. Currently taking any corticosteroid treatment including but not limited to oral and inhaled corticosteroid (within 4 weeks of trial). Inability to give informed consent and/or has no guardian. Flu shot within 6-8 weeks of test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To collect breath sample from uninfected subjects and those diagnosed with COVID 19 and compare the VOC pattern in each group to develop an algorithm for analysisTimepoint: At the end of the Study | — |
Secondary
| Measure | Time frame |
|---|---|
| To test the large group of COVID 19 positive and negative patients to develop the AI pattern-recognition program and to ascertain the test characteristics of the deviceTimepoint: At the end of the study | — |
Countries
India
Contacts
Public ContactProf Ashok Rattan
Divoc Laboratories
Outcome results
None listed